About Us

SMD is the longest standing and most established marine electronics company in Africa.

SMD was officially formed in 1957, but our roots go even further back to as far as 1939 when Mr. Horace Dainty, our founding partner, formed a company with his co-investors Smith & Matson. They linked their surnames together to form SMD Manufacturing Company.

During the war period, SMD’s efforts were primarily geared towards manufacturing of communications equipment for both UDF and British forces. During this time, they designed and manufactured specialized radio equipment such as the M17 radio.

After the war, Dainty quickly revitalized SMD manufacturing and development operations in the old SMD factory in Pinetown, Durban. SMD won a tender from the CSIR to develop the Wadely Reciever, which led to the developed RA17 for RACAL (UK), as well as manufactured hundreds of thousands transistor radios under the Eveready name to the local market.

Then in 1957, SMD registered SMD Telecommunications (Pty) Ltd as a separate marine division. The aim was to service the naval and merchant ships, headed up by Mr. Duncan Compton-James.

In the early 1960’s a number of things happened:

  • SMD formed a Joint Venture with RACAL and established RACAL-SMD.
  • Barlow Group acquires SMD Manufacturing Company and becomes Barlow Manufacturing Company
  • Racal increased their stake in RACAL-SMD and establishes their full presence in South Africa, namely Racal Electronics South Africa. Ultimately becoming the SAAB GRINTEK of today. During this time, Duncan Compton-Jones purchased the full equity in SMD Telecommunications (Pty) Ltd and moved operations to Cape Town where our head office is based today. During the 1990’s Duncan Crompton-Jones sold his shares in SMD to his senior staff member, Mr. Arend de Boer who also became the CEO.
  • In 2012, Grupoarbulu (Spain) acquired an 80% share in SMD, making SMD a part of one of the world’s leading marine electronics companies.
  • In 2014 Arend de Boer retired as CEO and is succeeded by Mr. Brian Chambers as MD.